Standardized report for early complications of radical prostatectomy

Wei-Ming Cheng1, Tzu-Ping Lin2, Chih-Chieh Lin2

  • 1Division of Urology, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.

Abstract

Insights

Radical prostatectomy (RP) complications within 90 days were analyzed using the Martin criteria. Overweight patients, those with diabetes, and those receiving neoadjuvant hormone therapy faced higher risks.

Area of Science:

  • Urology
  • Surgical Oncology
  • Patient Safety

Background:

  • Radical prostatectomy (RP) offers long-term survival for prostate cancer but carries risks.
  • The Martin criteria standardize complication reporting but are underutilized in Asian RP studies.
  • This study evaluated early RP complications in an Asian cohort using the Martin criteria.

Purpose of the Study:

  • To assess the incidence and types of early complications following radical prostatectomy (RP) within 90 days.
  • To apply the Martin criteria for standardized reporting of RP complications in an Asian population.
  • To identify predictors of early complications after RP.

Main Methods:

  • Retrospective review of 359 patients undergoing open, laparoscopic, or robot-assisted radical prostatectomy (RaLP) between 2003-2011.
  • Complications were identified within 90 days and graded using the Clavien-Dindo classification.
  • Preoperative, operative, and pathological data were analyzed to determine complication predictors.

Main Results:

  • Overall complication rate was 40.1%, with major complications at 13.1%; no surgical mortality occurred.
  • Leading complications included diarrhea (13.6%), minor urine leakage (9.5%), and gout attack (4.2%).
  • Minimally invasive RP showed higher rates of lymph leakage and upper-extremity neuropathy. Overweight, neoadjuvant hormone therapy, and diabetes mellitus predicted complications.

Conclusions:

  • Early complication rates in this Asian cohort were higher than Western series.
  • Standardized reporting identified overweight, diabetes mellitus, and neoadjuvant hormone therapy as key predictors.
  • These findings highlight the need for tailored management strategies in Asian patients undergoing RP.